Partnering with Science: New Hope for the Effective Treatment of Type 2 Diabetes
AbstractResearch scientists are exploring new physiological pathways and new therapeutics to regulate glucose in people living with type 2 diabetes. Studies have shown that fibroblast growth factor 21 (FGF-21) has the ability to regulate blood glucose levels; however, these effects are temporary. In another promising development, activation of the fibroblast growth factor receptor-1 (FGFR-1) using a specifically designed antibody has shown to be effective in regulating glucose and is capable of long residence times in the blood. Scientists are also exploring the role of FGF-1, another member of the FGF family, in fat remodeling and glucose regulation. It is possible that the regulation of blood glucose levels by FGF-1 might actually involve regulation of a neural pathway (as opposed to a systemic metabolic pathway). People living with diabetes can have hope that scientists are close to developing novel therapeutics to regulate glucose over an extended period of time.
Florida State University holds the copyright on all material appearing in PLAID, unless the content is produced by an employee of the U.S. government as part of the authors’ official duties.
Authors retain the right to post in an Institutional Repository or website the ‘postprint’ version of the article (i.e. the article in the form accepted for publication following the process of peer review), and the right to use the published journal article for personal use and internal institutional use.